EUVIMEDEUVIMED entdecken
Open Access

Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS

Tomoyuki Nanamiya, Kiyoko Takane, Kiyoshi Yamaguchi, Yuya Okawara, Mariko Arakawa, Akari Saku, Tsuneo Ikenoue, Tomoko Fujiyuki, Misako Yoneda, Chieko Kai, Yoichi Furukawa

Oncology Reports · 2023

DOI: 10.3892/or.2023.8676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Tomoyuki Nanamiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108‑8639, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Oncolytic Viruses, Nectins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsOncolytic VirusesNectinsFemaleHumansCell Adhesion MoleculesMeasles virusRNA, Small InterferingProto-Oncogene Proteins c-fos

Stichwörter der Autor:innen

FOSPVRL4breast cancernectin‑4

Substanzen

Cell Adhesion MoleculesRNA, Small InterferingNECTIN4 protein, humanNectinsProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108‑8639, Japan.
  • Division of Virus Engineering, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.
  • Division of Virological Medicine, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.
  • Division of Infectious Disease Control Science, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.

Zitieren

APA

Nanamiya, T., Takane, K., Yamaguchi, K., Okawara, Y., Arakawa, M., Saku, A., Ikenoue, T., Fujiyuki, T., Yoneda, M., Kai, C., & Furukawa, Y. (2023). Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. Oncology Reports. https://doi.org/10.3892/or.2023.8676

Vancouver

Nanamiya T, Takane K, Yamaguchi K, Okawara Y, Arakawa M, Saku A, et al. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. Oncology Reports. 2023. doi:10.3892/or.2023.8676

BibTeX
@article{Nanamiya2023,
  author = {Nanamiya, Tomoyuki and Takane, Kiyoko and Yamaguchi, Kiyoshi and Okawara, Yuya and Arakawa, Mariko and Saku, Akari and Ikenoue, Tsuneo and Fujiyuki, Tomoko and Yoneda, Misako and Kai, Chieko and Furukawa, Yoichi},
  title = {Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8676}
}
Kostenlos starten →